Strongbridge Biopharma plc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$11.3M

127 transactions

Summary

Strongbridge Biopharma plc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $8.8MSales: —16 insiders

Date	Insider	Type	Value
2021-10-05	Joint reporting: Kovner Bruce; CAXTON CORP; CDK ASSOCIATES, L.L.C.	J	—
2021-10-05	Joint reporting: Kovner Bruce; CAXTON CORP; CDK ASSOCIATES, L.L.C.	J	—
2021-10-05	LONG STEPHEN J(Chief Legal Officer)	D	—
2021-10-05	LONG STEPHEN J(Chief Legal Officer)	D	—
2021-10-05	GILL DAVID N	D	—
2021-10-05	Kong Garheng	D	—
2021-10-05	Kong Garheng	D	—
2021-10-05	SHERMAN JEFFREY W	D	—
2021-10-05	SHERMAN JEFFREY W	D	—
2021-10-05	Steen Marten	D	—
2021-10-05	Steen Marten	D	—
2021-10-05	Steineger Hilde H	D	—
2021-10-05	Steineger Hilde H	D	—
2021-10-05	JOHNSON JOHN(Chief Executive Officer)	D	—
2021-10-05	JOHNSON JOHN(Chief Executive Officer)	D	—
2021-10-05	Cohen Fredric J.(Chief Medical Officer)	D	—
2021-10-05	Cohen Fredric J.(Chief Medical Officer)	D	—
2021-10-05	Kollender Richard S(President and CFO)	D	—
2021-10-05	Kollender Richard S(President and CFO)	D	—
2021-10-05	Wilhoit Scott L.(Chief Commercial Officer)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Strongbridge Biopharma plc — Contributions, Lobbying & Contracts | Poliscope